You have 9 free searches left this month | to do more

baricitinib

Baricitinib is a drug used to treat Atopic Dermatitis, Rheumatoid Arthritis, Healthy Volunteers, and other conditions. Baricitinib is being actively studied in 40 studies and prior, has been studied in 30.

Top SponsorsTop SitesTop Investigators
Eli Lilly and CompanyFor additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.Abu Taiub Mohammed Mohiuddin Chowdhury
National Institute of Allergy and Infectious Diseases (NIAID)Hospital Universitario La PazAdeline Vanderver, MD
Adeline Vanderver, MDSheba Medical CenterAlex Ortega Loayza
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Withdrawn
  • COVID-19
  • Baricitinib
  • Aurora, Colorado
    University of Colorado, Denver
2021-03-03
Mar 3, 2021
U
Recruiting
  • COVID-19
  • Patras, Greece
    University Hospital of Patras, Department of Respiratory Medicin
2021-10-18
Oct 18, 2021
P
Not yet recruiting
  • Sjogren's Syndrome
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
2021-08-19
Aug 19, 2021
M
Completed
  • Arteritis, Giant Cell
  • Baricitinib
  • Rochester, Minnesota
    Mayo Clinic
2021-06-29
Jun 29, 2021
A
Not yet recruiting
  • Dermatomyositis
  • Baricitinib
  • Placebo
  • Paris, France
    Pitie-Salpêtrière hospital APHP
2021-07-12
Jul 12, 2021
O
Recruiting
  • Pyoderma Gangrenosum
  • +4 more
  • Baricitinib
  • Portland, Oregon
    Oregon Health and Science University
2021-09-08
Sep 8, 2021
M
Recruiting
  • Covid19
  • Covid-19 ARDS
  • Dinajpur, Bangladesh
    M. Abdur Rahim Medical College Hospital
2020-12-31
Dec 31, 2020
I
Not yet recruiting
  • Covid19
  • Baricitinib
  • Placebo
  • Dhaka, Bangladesh
    Dhaka Medical College, Mugda Medical College, Kuwait Bangladesh
2021-09-25
Sep 25, 2021
W
Recruiting
  • Allergic Contact Dermatitis
  • Baricitinib
  • Placebo
  • Fairborn, Ohio
    Wright State Physicians
2021-04-06
Apr 6, 2021
U
Recruiting
  • Polymyalgia Rheumatic (PMR)
  • Baricitinib
  • Placebos
  • Bordeaux, France
  • +3 more
2020-12-03
Dec 3, 2020
S
Recruiting
  • Type 1 Diabetes
  • Baricitinib
  • Placebo
  • North Adelaide, South Australia, Australia
  • +3 more
2021-02-25
Feb 25, 2021
B
Recruiting
  • COVID-19 Pneumonia
  • Baricitinib
  • +2 more
  • Comilla, Bangladesh
  • +6 more
2021-08-25
Aug 25, 2021
W
Recruiting
  • Graft-versus-host-disease
  • Graft Vs Host Disease
  • Baricitinib
  • Saint Louis, Missouri
    Washington University School of Medicine
2021-08-09
Aug 9, 2021
U
Active, not recruiting
  • Rheumatoid Arthritis
  • +2 more
  • Baricitinib
  • Erlangen, Bavaria, Germany
    Universitiy Hospital Erlangen
2021-01-14
Jan 14, 2021
E
Active, not recruiting
  • Nakajo-Nishimura Syndrome
  • +3 more
  • Baricitinib
  • Hiroshima-shi, Hiroshima-ken, Japan
  • +4 more
2021-10-14
Oct 14, 2021
H
Not yet recruiting
  • Pharmacological Action
  • Baricitinib
  • Prato, Tuscany, Italy
    Fabrizio Cantini
2020-04-19
Apr 19, 2020
U
Terminated
  • Symptomatic COVID-19 Infection Laboratory-Confirmed
  • Baricitinib
  • +2 more
  • Los Angeles, California
  • +1 more
2021-05-21
May 21, 2021
I
Not yet recruiting
  • Corona Virus Infection
  • Baricitinib
  • (no location specified)
2020-05-21
May 21, 2020
A
Active, not recruiting
  • Aicardi Goutieres Syndrome
  • Baricitinib
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
2021-07-29
Jul 29, 2021
E
Terminated
  • Primary Biliary Cholangitis
  • Baricitinib
  • Placebo
  • Coronado, California
  • +11 more
2020-09-18
Sep 18, 2020
U
Not yet recruiting
  • Idiopathic Inflammatory Myopathies
  • Baricitinib
  • (no location specified)
2019-12-19
Dec 19, 2019
E
Not yet recruiting
  • Covid19
  • Corona Virus Infection
  • Baricitinib
  • Orlando, Florida
  • +21 more
2021-10-12
Oct 12, 2021
N
Recruiting
  • Chronic Graft vs Host Disease
  • Chronic Graft-Versus-Host Disease
  • Baricitinib
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2021-10-13
Oct 13, 2021
E
Completed
  • Atopic Dermatitis
  • Baricitinib
  • +2 more
  • Los Angeles, California
  • +12 more
2020-06-10
Jun 10, 2020